AXURA(R)/AKATINOL(R) Enhances Communication Abilities In Patients With Alzheimer´s Disease - for A Longer Integration In Social And Family Life
Memantine improves functional communication skills in patients with moderate to severe Alzheimer’s disease (AD), noticeable by caregivers. These are the study results discussed at the International Conference on Alzheimer’s Disease (ICAD). The data of two recent clinical trials support that AXURA®/AKATINOL®- an uncompetitive NMDA receptor antagonist - effects language skills in AD patients and improves cognitive abilities and functional communication.
More: continued here
Filed under: Alzheimer's / Dementia News XML/RSS Feed on July 21st, 2009
You must be logged in to post a comment.